Implanet S.A., a Bordeaux, France-based Medical Device and Healthcare Information Technology company, raised an additional €8m (US$11m).
Investors include CM-CIC Private Equity, which committed €4m, and existing backers Edmond de Rothschild Investment Partners, Wellington Partners, Seventures Partners, Auriga Partners, as well as founders, management and several domain reference private investors such as Marie-Helene PLAIS-COTREL (ex Sofamor-Danek), which together provide €4m.
Commenting on the funding, Erick Cloix, CEO at Implanet, was quoted as saying: “This new round of financing concludes a first cycle of 3 years during which 30 million Euros were invested to prepare and develop a novel type of Healthcare Company addressing, at last, the paradigm shifting challenges of quality, security and financing of healthcare everywhere, particularly in Europe and the USA.
“The current economic and financial crisis along with the US health care reform in the USA is a catalyst for our technologies, our services and our business model.
“The new 2010-2012 cycle which opens for us looks formidable with opportunities and conquests”, he added.
Incorporated in early 2007, Implanet designs and manufactures surgical implants (HIP, KNEE, SPINE, and ARTHROSCOPY) exclusively in France and in Europe.